GUERRIERI, SIMONE
GUERRIERI, SIMONE
Facoltà di Medicina e Chirurgia
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response
2018-01-01 Romeo, M. A. L.; Martinelli, V.; Dalla Costa, G.; Colombo, B.; De Feo, D.; Esposito, F.; Ferre, L.; Guaschino, C.; Guerrieri, S.; Liberatore, G.; Martinelli Boneschi, F.; Merlini, A.; Messina, M.; Messina, R.; Nuara, A.; Preziosa, P.; Radaelli, M.; Rocca, M. A.; Rodegher, M.; Sangalli, F.; Strambo, D.; Moiola, L.; Comi, G.
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia
2021-01-01 Moroni, Luca; Mazzetti, Martina; Ramirez, Giuseppe Alvise; Farina, Nicola; Bozzolo, Enrica Paola; Guerrieri, Simone; Moiola, Lucia; Filippi, Massimo; Di Mattei, Valentina; Dagna, Lorenzo
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series
2024-01-01 Guerrieri, S.; Rubin, M.; Gattuso, I.; Zanetta, C.; Genchi, A.; Preziosa, P.; Rocca, M. A.; Filippi, M.; Moiola, L.
Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter?
2025-01-01 Filippi, Massimo; Margoni, Monica; Zaccone, Tiziana; Guerrieri, Simone; Rancoita, Paola Maria; Moiola, Lucia; Rocca, Maria Assunta
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study
2024-01-01 Zanandrea, Laura; Messina, Roberta; Cetta, Ilaria; Genovese, Federica; Guerrieri, Simone; Vernieri, Fabrizio; Altamura, Claudia; Cevoli, Sabina; Favoni, Valentina; Colombo, Bruno; Filippi, Massimo
Fast but not furious: Rapid ocrelizumab infusion as a strategy to optimize multiple sclerosis patients' management
2024-01-01 Zanetta, C.; Faustino, P.; Guerrieri, S.; Nozzolillo, A.; Genchi, A.; Bucca, C.; Rocca, M. A.; Moiola, L.; Filippi, M.
In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis
2019-01-01 Vabanesi, M.; Pisa, M.; Guerrieri, S.; Moiola, L.; Radaelli, M.; Medaglini, S.; Martinelli, V.; Comi, G.; Leocani, L.
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics
2024-01-01 Omrani, M.; Chiarelli, R. R.; Acquaviva, M.; Bassani, C.; Dalla Costa, G.; Montini, F.; Preziosa, P.; Pagani, L.; Grassivaro, F.; Guerrieri, S.; Romeo, M.; Sangalli, F.; Colombo, B.; Moiola, L.; Zaffaroni, M.; Pietroboni, A.; Protti, A.; Puthenparampil, M.; Bergamaschi, R.; Comi, G.; Rocca, M. A.; Martinelli, V.; Filippi, M.; Farina, C.
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience
2023-01-01 Guerrieri, Simone; Bucca, Chiara; Nozzolillo, Agostino; Genchi, Angela; Zanetta, Chiara; Cetta, Ilaria; Rugarli, Giulia; Gattuso, Irene; Azzimonti, Matteo; Rocca, Maria Assunta; SanRaf MS Study, Group; Preziosa, Paolo; Paolo, Moiola; Lucia, ; Filippi, Massimo
Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis
2021-01-01 Guerrieri, S.; Comi, G.; Leocani, L.
Sensitivity and predictive role of OCT and VEP in multiple sclerosis
2015-01-01 Di Maggio, G.; Santangelo, R.; Guerrieri, S.; Ferrari, L.; Vitali, F.; Medaglini, S.; Rodegher, M.; Colombo, B.; Moiola, L.; Del Carro, U.; Martinelli, V.; Comi, G.; Leocani, L.
Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience
2022-01-01 Guerrieri, S.; Lazzarin, S.; Zanetta, C.; Nozzolillo, A.; Filippi, M.; Moiola, L.
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes
2021-01-01 Pisa, M.; Croese, T.; Dalla Costa, G.; Guerrieri, S.; Huang, S. -C.; Finardi, A.; Fabbella, L.; Sangalli, F.; Colombo, B.; Moiola, L.; Martinelli, V.; Comi, G.; Furlan, R.; Leocani, L.
Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography
2020-01-01 Pisa, M.; Ratti, F.; Vabanesi, M.; Radaelli, M.; Guerrieri, S.; Moiola, L.; Martinelli, V.; Comi, G.; Leocani, L.
The visual pathway as a platform to assess demyelination and neurodegeneration in multiple sclerosis: the paradigms of acute optic neuritis and progressive course
2022-04-07 Guerrieri, Simone
U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene
2021-01-01 Sferruzza, Giacomo; Del Bondio, Andrea; Citterio, Andrea; Vezzulli, Paolo; Guerrieri, Simone; Radaelli, Marta; Martinelli Boneschi, Filippo; Filippi, Massimo; Maltecca, Francesca; Bassi, Maria Teresa; Scarlato, Marina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response | 1-gen-2018 | Romeo, M. A. L.; Martinelli, V.; Dalla Costa, G.; Colombo, B.; De Feo, D.; Esposito, F.; Ferre, L.; Guaschino, C.; Guerrieri, S.; Liberatore, G.; Martinelli Boneschi, F.; Merlini, A.; Messina, M.; Messina, R.; Nuara, A.; Preziosa, P.; Radaelli, M.; Rocca, M. A.; Rodegher, M.; Sangalli, F.; Strambo, D.; Moiola, L.; Comi, G. | |
| Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia | 1-gen-2021 | Moroni, Luca; Mazzetti, Martina; Ramirez, Giuseppe Alvise; Farina, Nicola; Bozzolo, Enrica Paola; Guerrieri, Simone; Moiola, Lucia; Filippi, Massimo; Di Mattei, Valentina; Dagna, Lorenzo | |
| Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series | 1-gen-2024 | Guerrieri, S.; Rubin, M.; Gattuso, I.; Zanetta, C.; Genchi, A.; Preziosa, P.; Rocca, M. A.; Filippi, M.; Moiola, L. | |
| Disability worsening outcome in multiple sclerosis based on EDSS: does half a point matter? | 1-gen-2025 | Filippi, Massimo; Margoni, Monica; Zaccone, Tiziana; Guerrieri, Simone; Rancoita, Paola Maria; Moiola, Lucia; Rocca, Maria Assunta | |
| Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study | 1-gen-2024 | Zanandrea, Laura; Messina, Roberta; Cetta, Ilaria; Genovese, Federica; Guerrieri, Simone; Vernieri, Fabrizio; Altamura, Claudia; Cevoli, Sabina; Favoni, Valentina; Colombo, Bruno; Filippi, Massimo | |
| Fast but not furious: Rapid ocrelizumab infusion as a strategy to optimize multiple sclerosis patients' management | 1-gen-2024 | Zanetta, C.; Faustino, P.; Guerrieri, S.; Nozzolillo, A.; Genchi, A.; Bucca, C.; Rocca, M. A.; Moiola, L.; Filippi, M. | |
| In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis | 1-gen-2019 | Vabanesi, M.; Pisa, M.; Guerrieri, S.; Moiola, L.; Radaelli, M.; Medaglini, S.; Martinelli, V.; Comi, G.; Leocani, L. | |
| Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics | 1-gen-2024 | Omrani, M.; Chiarelli, R. R.; Acquaviva, M.; Bassani, C.; Dalla Costa, G.; Montini, F.; Preziosa, P.; Pagani, L.; Grassivaro, F.; Guerrieri, S.; Romeo, M.; Sangalli, F.; Colombo, B.; Moiola, L.; Zaffaroni, M.; Pietroboni, A.; Protti, A.; Puthenparampil, M.; Bergamaschi, R.; Comi, G.; Rocca, M. A.; Martinelli, V.; Filippi, M.; Farina, C. | |
| Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience | 1-gen-2023 | Guerrieri, Simone; Bucca, Chiara; Nozzolillo, Agostino; Genchi, Angela; Zanetta, Chiara; Cetta, Ilaria; Rugarli, Giulia; Gattuso, Irene; Azzimonti, Matteo; Rocca, Maria Assunta; SanRaf MS Study, Group; Preziosa, Paolo; Paolo, Moiola; Lucia, ; Filippi, Massimo | |
| Optical Coherence Tomography and Visual Evoked Potentials as Prognostic and Monitoring Tools in Progressive Multiple Sclerosis | 1-gen-2021 | Guerrieri, S.; Comi, G.; Leocani, L. | |
| Sensitivity and predictive role of OCT and VEP in multiple sclerosis | 1-gen-2015 | Di Maggio, G.; Santangelo, R.; Guerrieri, S.; Ferrari, L.; Vitali, F.; Medaglini, S.; Rodegher, M.; Colombo, B.; Moiola, L.; Del Carro, U.; Martinelli, V.; Comi, G.; Leocani, L. | |
| Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience | 1-gen-2022 | Guerrieri, S.; Lazzarin, S.; Zanetta, C.; Nozzolillo, A.; Filippi, M.; Moiola, L. | |
| Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes | 1-gen-2021 | Pisa, M.; Croese, T.; Dalla Costa, G.; Guerrieri, S.; Huang, S. -C.; Finardi, A.; Fabbella, L.; Sangalli, F.; Colombo, B.; Moiola, L.; Martinelli, V.; Comi, G.; Furlan, R.; Leocani, L. | |
| Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography | 1-gen-2020 | Pisa, M.; Ratti, F.; Vabanesi, M.; Radaelli, M.; Guerrieri, S.; Moiola, L.; Martinelli, V.; Comi, G.; Leocani, L. | |
| The visual pathway as a platform to assess demyelination and neurodegeneration in multiple sclerosis: the paradigms of acute optic neuritis and progressive course | 7-apr-2022 | Guerrieri, Simone | |
| U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene | 1-gen-2021 | Sferruzza, Giacomo; Del Bondio, Andrea; Citterio, Andrea; Vezzulli, Paolo; Guerrieri, Simone; Radaelli, Marta; Martinelli Boneschi, Filippo; Filippi, Massimo; Maltecca, Francesca; Bassi, Maria Teresa; Scarlato, Marina |